Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

6 Dec 2013 17:46

RNS Number : 9748U
Ark Therapeutics Group PLC
06 December 2013
 



BLOCK LISTING SIX MONTHLY RETURN

 

Date: 6 December 2013

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Unapproved Share Option Scheme

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

2,271,252

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

2,271,252

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

939,433

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

939,433

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group 2005 Long Term Incentive Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

683,200

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

683,200

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Approved Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

1,000,000

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 002 1005

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDMMGZNVDGFZM
Date   Source Headline
6th Jun 20122:41 pmRNSBlocklisting Interim Review
18th May 201212:02 pmRNSHolding(s) in Company
18th May 201212:01 pmRNSDirector Dealings
18th May 201211:57 amRNSResult of AGM
17th May 20127:00 amRNSInterim Management Statement
16th May 20127:00 amRNSCompletion of Phase 1 Study
2nd May 20127:00 amRNSGrant and Patent Update
25th Apr 20127:00 amRNSRegulatory Approval of Manufacturing Suite
17th Apr 20122:36 pmRNSDirector/PDMR Shareholding
10th Apr 20127:00 amRNSNew Board Appointment
2nd Apr 20123:25 pmRNSAnnual Information Update
26th Mar 20127:00 amRNSChange of Broker Name
15th Mar 20124:09 pmRNSDirector/PDMR Shareholding
13th Mar 20124:16 pmRNSBoard Changes
12th Mar 20127:00 amRNSFinal Results
23rd Feb 20124:29 pmRNSHolding(s) in Company
9th Feb 201211:10 amRNSNotice of Results
8th Feb 20127:00 amRNSUS patent for Neuropilin-1 receptor
4th Jan 20127:00 amRNSManufacturing Update
7th Dec 201111:48 amRNSDirector/PDMR Shareholding
5th Dec 20112:35 pmRNSBlocklisting Interim Review
9th Nov 20117:00 amRNSInterim Management Statement
3rd Nov 20117:00 amRNSManufacturing agreement
16th Sep 20114:41 pmRNSSecond Price Monitoring Extn
16th Sep 20114:35 pmRNSPrice Monitoring Extension
12th Sep 20117:00 amRNSRe Agreement
24th Aug 20115:29 pmRNSHalf Yearly Report on National Storage Mechanism
24th Aug 20117:00 amRNSHalf Yearly Report - Part 2
24th Aug 20117:00 amRNSHalf Yearly Report - Part 1
1st Aug 20114:31 pmRNSHolding(s) in Company
29th Jul 20114:40 pmRNSSecond Price Monitoring Extn
29th Jul 20114:35 pmRNSPrice Monitoring Extension
25th Jul 20114:40 pmRNSSecond Price Monitoring Extn
25th Jul 20114:35 pmRNSPrice Monitoring Extension
18th Jul 20113:10 pmRNSHolding(s) in Company
14th Jul 20117:00 amRNSWins ?5.3 million EU Framework Programme 7 Grant
6th Jul 20117:00 amRNSArk receives Finnish Grants
4th Jul 20117:00 amRNSGrant of US patents and milestone payments
13th Jun 20114:40 pmRNSSecond Price Monitoring Extn
13th Jun 20114:35 pmRNSPrice Monitoring Extension
3rd Jun 201111:57 amRNSBlocklisting Interim Review
17th May 20117:00 amRNSInterim Management Statement
9th May 20113:28 pmRNSAGM Results
31st Mar 20111:43 pmRNSAnnual Information Update
30th Mar 20111:08 pmRNSDirector/PDMR Shareholding
24th Mar 20113:40 pmRNSAnnual Financial Report
9th Mar 20117:00 amRNSFinal Results
3rd Mar 20117:00 amRNSAppointment of CFO
2nd Mar 20117:00 amRNSDisposal
28th Feb 201111:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.